332 Terminate Acne
Product details
- Description
-
An essence for blemish-prone areas.
- Use during the early stages of skincare after cleansing.
- Its lightweight formula absorbs into the skin without feeling heavy.
- It does not sit on the surface or pill, leaving a comfortable finish.
- Suitable for daily use on skin where blemishes are a concern.
We strive to provide accurate product information. The information shown here was provided by the manufacturer, suppliers, and other sources and has not been verified by us. Please see our disclaimer.
- How to use
- 1) After cleansing, smooth the skin with toner. 2) Apply an appropriate amount to areas where blemishes are a concern. 3) Gently pat with your fingertips to help absorption. 4) Finish with the next skincare step.
- Brand / Product name
- / 332 Terminate Acne
- Category
- Skincare Essence/Serum Blemish Essence
What's in it?
Ingredients
The ingredient preference rating is a reference based on how users reviewed products containing this ingredient.
- Top — Consistently highly rated across categories
- High — Tends to rate above average
- Average — Near the overall average
- Low — Tends to rate below average
- Very low — Clear trend of low ratings
- Insufficient data — Not enough product and review data
- Not rated — Basic ingredient or unsuitable for star ratings
Ingredient preference ratings do not indicate an ingredient's efficacy or safety. They are based on user data to help you choose products.
-
Preference: Low data
Corylus Avellana Seed OilFragrance
Potential concerns 1 items
May provide nutrients for Malassezia yeast and worsen related folliculitis.
Key features
- Alcohol-free
- EU allergen-free
- Fragrance-free
- Oil-free
- Paraben-free
- Silicone-free
- Sulfate-free
- Reef-safe
- Fungal acne-safe
How it feels
There are no survey responses for this product yet.
Ask the community
Viewduc users haven’t asked any questions about 332 Terminate Acne yet.
Ratings & reviews
0
0 reviews
- 5 stars
- 4 stars
- 3 stars
- 2 stars
- 1 stars
This product has no reviews yet.
